{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2013-0212","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2013-0212","name":[{"text":"Dose 2 to dose 3 interval 8 wks-5 days in adolescent with two Recombivax not meeting rules for two dose adoles. 4th dose needed\nEvaluation_Test_Type: All Valid: Forecast Test\nGeneral_Description: This test case describes when dose #3 of the Hep B Recomibivax vaccine is administered at an interval of 8 weeks - 5 days from dose #2 to an adolescent child, that the dose is valid, but a fourth dose is required."}],"gender":"female","birthDate":"2006-09-29"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0212-dose1","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"43","display":"RECOMBIVAX-ADULT"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-ADULT"}]},"patient":{"reference":"Patient/2013-0212"},"occurrenceDateTime":"2020-01-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0212-dose2","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"43","display":"RECOMBIVAX-ADULT"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-ADULT"}]},"patient":{"reference":"Patient/2013-0212"},"occurrenceDateTime":"2020-04-29T00:00:00.000"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2013-0212-dose3","status":"completed","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"8","display":"RECOMBIVAX-PEDS"},{"system":"http://hl7.org/fhir/v2/0227","code":"MSD","display":"RECOMBIVAX-PEDS"}]},"patient":{"reference":"Patient/2013-0212"},"occurrenceDateTime":"2020-06-19T00:00:00.000"}}]},"request":{"method":"PUT","url":"Parameters"}},{"resource":{"resourceType":"Parameters","parameter":[{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0212-dose1-evaluation","status":"completed","patient":{"reference":"Patient/2013-0212"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0212-dose1"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0212-dose2-evaluation","status":"completed","patient":{"reference":"Patient/2013-0212"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0212-dose2"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2013-0212-dose3-evaluation","status":"completed","patient":{"reference":"Patient/2013-0212"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2013-0212-dose3"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0212"},"date":"2020-06-29T00:00:00.000","recommendation":[{"forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"notComplete","display":"Not Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2020-06-24T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2020-06-24T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2020-06-24T00:00:00.000"}],"description":"Evaluation_Test_Type: All Valid: Forecast Test\nForecast_Test_Type: EvaluationRecommended based on interval \nGeneral_Description: This test case describes when dose #3 of the Hep B Recomibivax vaccine is administered at an interval of 8 weeks - 5 days from dose #2 to an adolescent child, that the dose is valid, but a fourth dose is required.","series":"HepB","doseNumberPositiveInt":4}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}